深圳市金黄色葡萄球菌耐药性分析及分子分型

目的 了解深圳市金黄色葡萄球菌的耐药性特点及分子分型特征。方法 收集2012年来自深圳市7所医院的428株金黄色葡萄球菌,以琼脂稀释法测定其对12种抗菌药物的最低抑菌浓度（MIC）,采用聚合酶链式反应（PCR）检测杀白细胞毒素（PVL）,并对携带PVL基因的菌株进行多位点基因序列分型（MLST）。结果 428株金黄色葡萄球菌中耐甲氧西林金黄色葡萄球菌（MRSA）116株（26.2%）,甲氧西林敏感金黄色葡萄球菌（MSSA）312株（73.8%）。12种抗菌药物中,该菌对青霉素和红霉素的耐药率最高,分别为88.8%和44.2%;未发现替考拉宁、利奈唑胺和万古霉素的耐药株。MRSA对青霉素和环丙沙星的耐药率显著高于MSSA。428株金黄色葡萄球菌中,60株（14.02%）携带PVL基因。MLST分型结果显示共有14种已知序列型和4种新的序列型,其中ST59和ST338最多,分别为16株和12株。结论 深圳地区金黄色葡萄球菌MRSA检出率以及对多种抗菌药物的耐药率均低于全国平均水平,PVL基因阳性率处于中等水平;存在多种ST分型,以ST59和ST338多见,具有遗传多样性和独特的遗传背景。     

Identification and functional characterization of phenylglycine biosynthetic genes involved in pristinamycin biosynthesis in Streptomyces pristinaespiralis

Pristinamycin I (PI), a streptogramin type B antibiotic produced by Streptomyces pristinaespiralis, contains the aproteinogenic amino acid l-phenylglycine. Recent sequence analysis led to the identification of a set of putative phenylglycine biosynthetic genes. Successive inactivation of the individual genes resulted in a loss of PI production. Production was restored by supplementation with externally added l-phenylglycine, which demonstrates that these genes are involved in phenylglycine biosynthesis and thus probably disclosing the last essential pristinamycin biosynthetic genes. Finally, a putative pathway for phenylglycine synthesis is proposed.     

Production of flavor esters by lipases of Staphylococcus warneri and Staphylococcus xylosus

The present paper describes the potential of Staphylococcus warneri and Staphylococcus xylosus lipases in the production of a variety of flavor esters. Both immobilized lipases produced ethyl esters from hexanoic to oleic acids with an optimum at decanoic acid. They esterified aliphatic and branched chain primary alcohols from ethanol to hexanol. Under our standard conditions, acetic, butyric, 2-methyl butyric, 3-methyl butyric, and valeric acids underwent slight esterification.     

薰衣草精油和芦荟对痤疮面部主要菌群的影响

目的 体外观察薰衣草精油和芦荟水提物对痤疮患者面部痤疮丙酸杆菌和表皮葡萄球菌的作用,为改善面部痤疮治疗提供理论依据.方法 采用连续梯度稀释法稀释薰衣草精油及芦荟水提物,纸片法观察不同浓度的精油和芦荟水提物对面部正常菌群表皮葡萄球菌和痤疮主要致病菌痤疮丙酸杆菌的作用;通过抑菌环的大小反应抑菌作用强弱,测定生长曲线以观察对细菌生长繁殖的影响.结果 薰衣草精油对痤疮丙酸杆菌的抑菌作用明显强于表皮葡萄球菌(P＜0.05);两种芦荟(库拉索芦荟和木立芦荟)对痤疮丙酸杆菌均无抑菌作用(P＞0.05);库拉索芦荟对表皮葡萄球菌有微弱的抑制作用(P＜0.05);木立芦荟对表皮葡萄球菌生长有促进作用.结论 薰衣草精油和芦荟水提物对痤疮患者面部主要细菌表皮葡萄球菌和痤疮丙酸杆菌的作用效果不同,薰衣草精油和木立芦荟水提物联合应用有可能通过调整面部微生态平衡从而改善痤疮症状.     

噬菌体及其裂解酶控制金黄色葡萄球菌的研究进展

近70年来,由于抗生素的广泛使用,耐药金黄色葡萄球菌不断出现。美国1999～2005年因感染耐甲氧西林金黄色葡萄球菌（MRSA）而入院的患者增加1倍多,其中诊断为败血症的患者增加81．2％。因此,寻找控制耐药菌的新对策十分迫切。目前有望替代抗生素的控菌手段有抗菌肽、噬菌体等。其中,噬菌体的发现早于抗生素,后因抗生素的普及而被忽视。如今,耐药菌株的流行使噬菌体治疗再次受到关注。本文就应用噬菌体及其裂解酶控制金黄色葡萄球菌的研究进展进行综述。     

金黄色葡萄球菌基因表达的DNA扣除法

[目的]金黄色葡萄球菌作为一种分布广泛的致病微生物和研究革兰氏阳性菌遗传背景的模式菌株,利用real-time RT PCR对相关毒素及调控基因进行表达定量分析,在生物、医学、食品检测等领域具有较大研究价值.[方法]对制备好的反转录(RT,含有cDNA和DNA)和非反转录(RTˉ,仅含DNA)样品进行Real-time PCR检测,根据经典(1 E)ˉ△△Ct相对定量算法并结合PCR效率公式建立一种基因表达相对定量分析的DNA扣除法,将得到的Ct值转换为各样品含量,从RT样品中扣除RTˉ样品的量,无需DNaseⅠ酶解处理就可以去除DNA的影响,RTˉ样品的检测结果还可同时作为稳定的DNA内参.[结果]采用以上方法分析金黄色葡萄球菌肠毒素A基因(sea)、16S rRNA和RNA Ⅲ的表达情况,在含有葡萄糖的NB培养基中sea的相对转录水平随着葡萄糖浓度的增大而升高,RNAⅢ的相对转录水平随葡萄糖浓度的变化而产生小幅度的波动,16S rRNA在菌体生长初期时的表达量较为稳定;与绝对定量法比较,结果差异较小(均小于15%),且差异不显著(p＞0.05).[结论]这种基于DNA扣除法的Real-time RT PCR相对定量方法可以有效的对金黄色葡萄球菌的基因表达进行分析.     

替考拉宁与万古霉素治疗MRSA下呼吸道感染的临床疗效和安全性分析

目的 对替考拉宁与万古霉素治疗耐甲氧西林金黄色葡萄球菌（MRSA）下呼吸道感染的临床疗效和安全性进行分析。方法 回顾性分析2013年6月至2014年12月我院收治的53例MRSA下呼吸道感染患者的临床资料,其中22例应用替考拉宁治疗（替考拉宁组）,31例应用万古霉素治疗（万古霉素组）;分别对其治疗前后的临床症状、体征、临床疗效、细菌清除情况以及不良反应进行分析,并将临床分离菌分别进行替考拉宁和万古霉素的体外药敏试验。结果 替考拉宁组治疗时间平均（9.2±3.1）d,显著性低于万古霉素组的（14.9±3.3）d（t=63517,P0.05）。替考拉宁组细菌清除率为72.7%,万古霉素组为83.9%,两组比较差异无统计学意义（2=0.972,P>0.05）。药敏试验结果显示替考拉宁和万古霉素对痰液MRSA分离菌均有极强的抗菌活性。替考拉宁组出现与药物很可能和可能有关的不良反发生率为9.1%,万古霉素组为16.1%,两组比较差异无统计学意义（2=0.062,P>0.05）。结论 替考拉宁和万古霉素治疗MRSA下呼吸道感染疗效均较好,安全性高,但替考拉宁较之万古霉素使用时间更短。     

Letter to the Editor: 1H, 15N and 13C NMR Resonance Assignments of Staphostatin A, a Specific Staphylococcus Aureus Cysteine Proteinase Inhibitor

The increasing antibiotic resistance of an important human pathogen Staphylococcus aureus calls for the development of new therapeutic strategies. Staphylococcal cysteine proteases have been suggested as targets for such therapies. The recent discovery of staphostatins, specific protein inhibitors of these enzymes, gives prospects for the design and production of synthetic, low molecular weight analogs which might become drugs. We have decided to structurally characterize staphostatin A, a representative inhibitor of staphylococcal cysteine proteases, and to assess its binding mode to the target protease with the view of clarifying the specificity determinants. Here we report the (1)H, (15)N and (13)C NMR resonance assignments of staphostatin A.     

Effect of phage therapy on the turnover and function of peripheral neutrophils

The aim of this investigation was to establish the impact of phage therapy on the turnover and function of circulating neutrophils in 37 patients with suppurative bacterial infections. We determined the levels of circulating neutrophils and their precursors before therapy, after 3 weeks of therapy, and at a distant time interval (3 months) following the beginning of therapy. In addition, we measured the ability of neutrophils to phagocytize Staphylococcus aureus in vitro. Eight healthy blood donors served as a control group. The results showed that, among the studied parameters, the significant changes involved neutrophil precursor count and the ability of neutrophils to phagocytize bacteria. The percentage of neutrophils in patients before therapy was lower than in healthy donors (mean 58.0, versus 61.4). This value dropped further in patients after 3 months of following the therapy (mean 55.6). The content of neutrophil precursors, on the other hand, was lower in healthy donors than in patients before therapy (mean 2.5, versus 3.8). After 3 weeks of the therapy and after 3 months, the levels of neutrophil precursors were significantly higher (mean 4.8 and 4.9, respectively) than in control donors. The phagocytic index was lower in patients before therapy than in control donors (mean 66.3, versus 70.1) and decreased further after 3 weeks of therapy (mean 59.0) and after 3 months (mean 59.6). The results of this investigation indicate that successful phage therapy accelerates the turnover of neutrophils, accompanied by a decrease in their ability to phagocytize bacteria.     

Identification of a new putative enterotoxin SEU encoded by the egc cluster of Staphylococcus aureus

AIMS: This paper reports on a new putative enterotoxin SEU encoded by the enterotoxin gene cluster egc from Staphylococcus aureus and on a real-time polymerase chain reaction (PCR) assay for detecting the seu gene. METHODS AND RESULTS: PCR and sequencing revealed a new putative enterotoxin SEU encoded by some egc clusters. The seu gene resulted from sequence divergence in the psient1 and psient2 pseudogenes previously described in the egc cluster (Jarraud et al. [2001] Journal of Immunology166, 669). The presence of the seu gene was investigated in a collection of S. aureus strains by conventional PCR and by a specific 5'-nuclease PCR assay. Among the 24 strains harbouring the egc cluster, four tested positive for the seu gene. CONCLUSIONS: The existence of the seu gene adds to the number of newly described se genes and underlines the need for a better understanding of their role in the pathogenesis of S. aureus. SIGNIFICANCE AND IMPACT OF THE STUDY: A thorough study of the seu gene should provide further insight into the phylogenetics of the staphylococcal enterotoxins.